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The aim of this study was to analyse, with respect to previous studies, the role of the 
phytoestrogen Ferutinin in avoiding bone loss due to estrogen deficiency. The protocol 
included 30 female 7 week-old Sprague Dawley rats, divided into 6 groups of 5 rats 
each: 1) Sham-operated controls (SHAM), 2) OVX controls (C-OVX), 3) OVX treated 
with ferutinin (F-OVX) 0.5mg/Kg/day, 4) F-OVX 1mg/Kg/day, 5) F-OVX 2mg/Kg/
day, 6) OVX treated with estradiol benzoate (EB-OVX) 1.5 µg/rat twice a week. The 
treatments started the day after the ovariectomy and lasted for 30 days. Tetracycline 
double labelling was performed 20 and 5 days before sacrifice. Histomorphometrical 
analyses were performed on trabecular bone of the 4th/5th lumbar vertebrae and distal 
femoral epiphyses, as well as on cortical bone of vertebral bodies and femoral diaphy-
ses. At the end of the treatments very low ponderal increments were recorded in all F-
OVX groups (2-4%) with respect to SHAM/EB-OVX (10%) and C-OVX (30%). Although 
the great ponderal differences between all F-OVX groups and C-OVX that should imply 
a decrease of bone mass in F-OVX groups, trabecular bone volume (BV/TV) in lumbar 
vertebrae didn’t show significant differences, suggesting that ferutinin, opposing estro-
gen deficiency, inhibits osteoclast activity. Bone areas of cortical bone measured between 
double labels were always low in all F-OVX groups and high in C-OVX group with 
respect to all the others, suggesting that these skeletal regions are mainly devoted in 
answering the mechanical demands. On the contrary BV/TV of femoral distal epiphy-
ses resulted lower in C-OVX with respect to all other groups, suggesting that they are 
mainly devoted in answering the metabolic demands. This agrees with urinary DPD (an 
osteoclast activity marker) whose levels are significantly higher in C-OVX with respect 
to all other groups. In conclusion, our results suggest that ferutinin role, in preventing 
osteoporosis, due to estrogen deficiency, is expressed in inhibiting osteoclast erosion 
rather than in enhancing osteoblast deposition (as previously suggested); moreover, in 
all F-OVX groups the bone turnover is very low and seems correlated to the trivial body 
weight increase, which, in turn, depends on ferutinin treatment. 
